Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Oesophagus » Neoplasie 25. Januar 2020
Suchen
Gastroplattform
Neoplasie
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Magen-Darm
Oesophagus
Motilitätsstörungen
Neoplasie
Anderes
Pankreas
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 1233  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 24655  
   
The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
PLoS One
Lee JM, Park YM, Yun JS, Ahn YB, Lee KM, Kim DB, Lee JM, Han K, Ko SH.
PMID: 31978054 [PubMed - in process]


Enhanced recovery pathways vs standard care pathways in esophageal cancer surgery: systematic review and meta-analysis.
Esophagus
Triantafyllou T, Olson MT, Theodorou D, Schizas D, Singhal S.
PMID: 31974853 [PubMed - as supplied by publisher]


Postoperative Chemotherapy for Thoracic Pathological T3N0M0 Esophageal Squamous Cell Carcinoma.
Ann Surg Oncol
Wang Q, Peng L, Li T, Dai W, Jiang Y, Xie T, Fang Q, Wang Y, Wu L, Cao B, Han Y, Lang J.
PMID: 31974708 [PubMed - as supplied by publisher]


Birthweight, childhood overweight, height and growth and adult cancer risks: a review of studies using the Copenhagen School Health Records Register.
Int J Obes (Lond)
Aarestrup J, Bjerregaard LG, Meyle KD, Pedersen DC, Gjærde LK, Jensen BW, Baker JL.
PMID: 31974406 [PubMed - as supplied by publisher]


Correlation between MDM2 T309G single nucleotide polymorphism and esophageal cancer susceptibility: An updated meta-analysis.
Thorac Cancer
Yin L, Shen G, Zhu B.
PMID: 31970867 [PubMed - as supplied by publisher]


Cumulative Evidence for Associations Between Genetic Variants and Risk of Esophageal Cancer.
Cancer Epidemiol Biomarkers Prev
Li G, Song Q, Jiang Y, Cai A, Tang Y, Tang N, Yi D, Zhang R, Wei Z, Liu D, Chen J, Zhang Y, Liu L, Wu Y, Zhang B, Yi D.
PMID: 31969372 [PubMed - as supplied by publisher]


18F- FDG PET/CT-derived parameters predict clinical stage and prognosis of esophageal cancer.
BMC Med Imaging
Mantziari S, Pomoni A, Prior JO, Winiker M, Allemann P, Demartines N, Schäfer M.
PMID: 31969127 [PubMed - in process]


Validity of studies suggesting preoperative chemotherapy for resectable thoracic esophageal cancer: A critical appraisal of randomized trials.
World J Gastrointest Oncol
Manzini G, Klotz U, Henne-Bruns D, Kremer M.
PMID: 31966919 [PubMed]


Precision medicine for gastrointestinal cancer: Recent progress and future perspective.
World J Gastrointest Oncol
Matsuoka T, Yashiro M.
PMID: 31966910 [PubMed]


A Competing Risk Analysis Study of Prognosis in Patients with Esophageal Carcinoma 2006-2015 Using Data from the Surveillance, Epidemiology, and End Results (SEER) Database.
Med Sci Monit
Yu Z, Yang J, Gao L, Huang Q, Zi H, Li X.
PMID: 31966000 [PubMed - in process]


Added value of MRI to endoscopic and endosonographic response assessment after neoadjuvant chemoradiotherapy in oesophageal cancer.
Eur Radiol
Vollenbrock SE, van Dieren JM, Voncken FEM, van Turenhout ST, Kodach LL, Hartemink KJ, van Sandick JW, Aleman BMP, Beets-Tan RGH, Bartels-Rutten A.
PMID: 31965258 [PubMed - as supplied by publisher]


A nationwide population-based study to access the risk of metachronous esophageal cancers in head and neck cancer survivors.
Sci Rep
Tseng CM, Wang HH, Lee CT, Tai CM, Tseng CH, Chen CC, Tsai YN, Chen TH, Hsu MH, Wang CC, Hwang TZ, Wang HP, Wang WL.
PMID: 31964952 [PubMed - in process]


Accuracy of the revised Vienna Classification for predicting postendoscopic resection outcomes for gastric and oesophageal neoplasms: a retrospective cohort study of patients from a UK tertiary referral centre.
J Clin Pathol
Kuan J, Ratcliffe E, Hayes S, McGrath S, Ang Y.
PMID: 31959615 [PubMed - as supplied by publisher]


Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER).
Ann Oncol
Moehler M, Maderer A, Thuss-Patience PC, Brenner B, Meiler J, Ettrich TJ, Hofheinz RD, Al-Batran SE, Vogel A, Mueller L, Lutz MP, Lordick F, Alsina M, Borchert K, Greil R, Eisterer W, Schad A, Slotta-Huspenina J, Van Cutsem E, Lorenzen S.
PMID: 31959339 [PubMed - in process]


Predictive Value of Excision Repair Cross-Complementation Group 1 in the Response to Platinum-Based Chemotherapy in Esophageal Cancer: A Meta-Analysis.
Oncol Res Treat
Zhuo ZG, Zhu YK, Deng HY, Li G, Luo J, Alai GH, Lin YD.
PMID: 31958797 [PubMed - as supplied by publisher]


Patient-reported symptoms following diagnosis in esophagus cancer patients treated with palliative intent.
Dis Esophagus
Davis LE, Gupta V, Allen-Ayodabo C, Zhao H, Hallet J, Mahar AL, Ringash J, Doherty M, Kidane B, Darling G, Coburn NG.
PMID: 31957801 [PubMed - as supplied by publisher]


A prospective comparative study between concurrent chemoradiation with brachytherapy boost with concurrent chemoradiation alone in locally advanced cancer esophagus.
South Asian J Cancer
Tudu R.
PMID: 31956613 [PubMed]


Expression of MMP-14 and prognosis in digestive system carcinoma: a meta-analysis and databases validation.
J Cancer
Duan F, Peng Z, Yin J, Yang Z, Shang J.
PMID: 31956360 [PubMed]


Perioperative immunonutrition in esophageal cancer patients undergoing esophagectomy: the first meta-analysis of randomized clinical trials.
Dis Esophagus
Mingliang W, Zhangyan K, Fangfang F, Huizhen W, Yongxiang L.
PMID: 31950146 [PubMed - as supplied by publisher]


Efficacy of irinotecan-based chemotherapy after exposure to an anti-PD-1 antibody in patients with advanced esophageal squamous cell carcinoma.
Chin J Cancer Res
Zhang B, Wang X, Li Q, Mo H, Wang X, Song Y, Xu J, Qu T, Huang J.
PMID: 31949393 [PubMed]


   
   Artikel 1 - 20 / 24655    Seite 1 von 1233  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1